Nafamostat mesylate prevents metastasis and dissemination of neuroblastoma through vascular endothelial growth factor inhibitionMari Morimoto(Mie University), Masahiro Hirayama(Mie University)Molecular and Clinical OncologyJuly 21, 202210.3892/mco.2022.2571Cited by 3SaveCiteExport RISWatch citationsRelated PapersPharmacologic inhibition of BMI1 exerts antitumor effects against MYCN-amplified neuroblastoma, with activation of the p53 pathway|Scientific Reports|2025|0